They're back. After The Texas Medical Board's ten-year battle to stop Dr. Burzynski from treating cancer patients ended in Burzynski's victory in the Texas State Supreme Court in 1996—the Texas Medical Board is making another dangerous attempt at shutting him down—again. On April 11, 2012, the Texas Medical Board will try to revoke Dr. Burzynski's medical license, resulting in the closure of his clinic, the abandonment of all his patients, and risking any possibility of Antineoplastons gaining FDA-approval.



No different than the levels of absurdity and underhanded tactics clearly outlined in the original documentary about Dr. Burzynski—the Texas Medical Board is up to the same dirty tricks. This time, they will have the entire world watching, and the entire world fighting back to stop this trial from happening—and that means you.



First, watch the video above and send it to friends. Not only does it outline the charges involved in this case, but it also gives you a glimpse at a new side of Dr. Burzynski's treatment. Much of the footage used in this short film was initially intended for the "Chapter 2" documentary—so it also serves as a sneak peek into the new documentary about Dr. Burzynski that also covers the story from 2000 up until today—to be released in 2012.



Second, we need you to write letters, send faxes, make phone calls, and send emails starting with Governor Rick Perry, since he appointed the heads of the Texas Medical Board. Once you have done this, we ask that you also write, call, fax and email as many of the Texas representatives as you have time for. If you are friends or have connections with a your local Congressmen or Senators, urge them to pay attention to this issue as well. Remember, this isn't about Texas, it's about our right as a human race to choose our own cancer treatment—and not allow decades of important gene-targeted cancer research to be flushed down the toilet in the name of protecting the profits of an industry that doesn't want Burzynski to survive.

Since Burzynski was forced to administer the treatment only as part of a registered trial, some sixty Phase II trials have been registered with clinicaltrials.gov. No results of any of these trials have been published.

In December 2010, a planned Phase III trial was registered but it subsequently did not open for patient recruitment.[27]